Axq Capital, LP United Therapeutics Corp Transaction History

Axq Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$210.76 - $249.51 $800,888 - $948,138	-3,800 Reduced 65.45%	2,006 $461 Million
Q4 2023 Feb 13, 2024	BUY	$214.88 - $256.94 $537,200 - $642,350	2,500 Added 75.62%	5,806 $1.28 Billion
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $467,274 - $547,617	2,206 Added 200.55%	3,306 $747 Million
Q2 2023 Aug 11, 2023	BUY	$205.19 - $232.99 $225,709 - $256,289	1,100 New	1,100 $243 Million

673

42.2M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Axq Capital, LP with notifications on news.